Published in J Vasc Surg on September 01, 1989
Characterization of endothelial basement membrane nanotopography in rhesus macaque as a guide for vessel tissue engineering. Tissue Eng Part A (2009) 1.27
Tissue engineering of blood vessel. J Cell Mol Med (2007) 1.20
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
Covalent linkage of heparin provides a stable anti-coagulation surface of decellularized porcine arteries. J Cell Mol Med (2009) 0.85
Cryopreserved saphenous vein allografts for below-knee lower extremity revascularization. Ann Surg (1994) 0.81
Polymeric materials for tissue engineering of arterial substitutes. Vascular (2009) 0.80
Above-knee femoropopliteal bypass grafts and the consequences of graft failure. Ann R Coll Surg Engl (1993) 0.78
Metal mesh scaffold for tissue engineering of membranes. Tissue Eng Part C Methods (2011) 0.75
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17
A clinical prediction rule for delirium after elective noncardiac surgery. JAMA (1994) 5.92
Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology (1993) 3.07
Transformation of human lymphocytes: inhibition by homologous alpha globulin. Science (1968) 2.55
Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg (1995) 2.38
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1990) 2.37
Inputs into coronary care during 30 years. A cost effectiveness study. Ann Intern Med (1974) 2.24
The effects of injury on the adaptive immune response. Shock (1999) 2.07
Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology (1996) 1.97
The high cost of low-frequency events: the anatomy and economics of surgical mishaps. N Engl J Med (1981) 1.94
Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg (1980) 1.85
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro. J Immunol (1972) 1.79
Isolation of an immunosuppressive peptide fraction from human plasma. J Immunol (1973) 1.70
High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest (2000) 1.67
Severe Clostridium difficile colitis. Dis Colon Rectum (1995) 1.59
Muscle surface pH as an index of peripheral perfusion in man. Ann Surg (1971) 1.57
Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg (1984) 1.55
The reduction of mortality of abdominal aortic aneurysm resection. Am J Surg (1977) 1.54
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet (1999) 1.53
Carotid endarterectomy: preoperative evaluation of candidates with combined Doppler sonography and MR angiography. Work in progress. Radiology (1993) 1.51
Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma (1984) 1.49
Competitive blockade of lymphocyte stimulation by a serum immuno-regulatory alpha globulin (IRA). Transplant Proc (1969) 1.47
Screening for hypercoagulable states in vascular surgical practice: a preliminary study. J Vasc Surg (1990) 1.47
Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem (1994) 1.46
Reperfusion pulmonary edema. JAMA (1989) 1.46
Axillofemoral bypass graft. A safe alternative to aortoiliac reconstruction. N Engl J Med (1968) 1.45
Sequential helical CT angiography of aortoiliac disease. AJR Am J Roentgenol (1996) 1.44
Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg (1997) 1.43
Two decades of abdominal aortic aneurysm repair: have we made any progress? J Vasc Surg (2000) 1.42
Causes of primary graft failure after in situ saphenous vein bypass grafting. J Vasc Surg (1992) 1.36
Resource-based relative values for invasive procedures performed by eight surgical specialties. JAMA (1988) 1.33
Success of bypass vein grafts in patients with isolated popliteal artery segments. Surgery (1967) 1.30
Regulation of T lymphocyte function by immunoregulatory alphaglobulin (IRA). J Immunol (1974) 1.29
Secondary femoropopliteal reconstruction. Ann Surg (1981) 1.29
Health-related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med (1997) 1.28
Association of a circulating immunosuppressive polypeptide with operative and accidental trauma. Ann Surg (1977) 1.26
Prolongation of allograft survival by an alpha globulin isolated from normal blood. Transplantation (1967) 1.24
The late results of axillofemoral grafts. Surgery (1970) 1.23
Cytokines, sepsis and immunomodulation. Br J Surg (1993) 1.23
Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. N Engl J Med (1974) 1.22
The cost-effectiveness of endovascular repair versus open surgical repair of abdominal aortic aneurysms: A decision analysis model. J Vasc Surg (1999) 1.22
Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg (1989) 1.19
Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann Surg (1997) 1.19
Effects of acidosis and alkalosis on surface skeletal muscle hydrogen ion activity. Surg Gynecol Obstet (1969) 1.17
Peripheral arterial complications of intra-aortic ballon counterpulsation. Surgery (1977) 1.16
Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo. J Immunol (1981) 1.15
Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients. Arch Surg (1982) 1.14
Mechanisms of post-intervention arterial remodelling. Cardiovasc Res (2012) 1.13
Depressed immune response in burn patients: use of monoclonal antibodies and functional assays to define the role of suppressor cells. Ann Surg (1982) 1.13
Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery (1988) 1.12
The role of prostaglandin E2 in immune suppression following injury. Ann Surg (1991) 1.12
Renal transplantation in two cases of amyloidosis. Lancet (1971) 1.11
Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. N Engl J Med (1986) 1.11
Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery (1996) 1.10
The effect of tumor size on concomitant tumor immunity. Cancer Res (1973) 1.10
Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res (1980) 1.09
The effect of nonspecific immune stimulation with corynebacterium parvum on patterns of tumor growth. Cancer (1970) 1.09
Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch Surg (1999) 1.08
Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma. Ann Surg (1979) 1.08
Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J Biol Chem (2000) 1.08
Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA). Ann Surg (1981) 1.08
Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J Biol Chem (1997) 1.08
Isolation of an immunosuppressive peptide fraction from the serum of cancer patients. Cancer Res (1975) 1.07
Severe injury triggers antigen-specific T-helper cell dysfunction. Shock (1999) 1.07
Infrainguinal reconstruction for patients with chronic renal insufficiency. J Vasc Surg (1993) 1.07
Generation of suppressor cells in mice after surgical trauma. J Clin Invest (1980) 1.07
Management and mortality in resection of abdominal aortic aneurysms. A study of 114 cases. Am J Surg (1970) 1.07
Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann Surg (2000) 1.06
Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch Surg (1992) 1.06
Preparation and in vitro assay of effective and ineffective antilymphocyte sera. Surgery (1969) 1.06
Renal vein renin activity in the prognosis of surgery for renovascular hypertension. Am J Med (1969) 1.06
The impact of gender on the results of arterial bypass with in situ greater saphenous vein. Am J Surg (1995) 1.05
Spontaneous aortic dissection and rupture in a patient with neurofibromatosis. J Vasc Surg (2001) 1.05
Does the route of feeding modify the inflammatory response? Ann Surg (1994) 1.04
Peripheral arterial complications of left heart catheterization and their management. Am J Surg (1973) 1.04
Selective evaluation and management of coronary artery disease in patients undergoing repair of abdominal aortic aneurysms. A 16-year experience. Ann Surg (1990) 1.03
Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Ann Surg (1994) 1.03
Changing clinical trends in patients with peripheral arterial emboli. Surgery (1976) 1.03
Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells. J Biol Chem (1992) 1.03
Humoral immunosuppressive factors. Transplant Proc (1976) 1.03
Assessment of myocardial performance and optimal volume loading during elective abdominal aortic aneurysm resection. Arch Surg (1977) 1.03
Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery (1997) 1.02
Is axillo-bilateral femoral graft an effective substitute for aortic-bilateral iliac/femoral graft?: an analysis of ten years experience. Ann Surg (1977) 1.02
Changes in T lymphocyte subsets following injury. Assessment by flow cytometry and relationship to sepsis. Ann Surg (1985) 1.02
Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery (1984) 1.01
Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg (1998) 1.00
Suppressive serum, suppressor lymphocytes, and death from burns. Ann Surg (1981) 1.00
The cost of misadventures in colonic surgery. A model for the analysis of adverse outcomes in standard procedures. Am J Surg (1978) 1.00
A comparison of the late patency rates of axillobilateral femoral and axillounilateral femoral grafts. Surgery (1977) 1.00
The effect of polyinosinic-polycytidylic acid on the immune response of mice to antigenically distinct tumors. Cancer Res (1972) 1.00
Volume loading and vasodilators in abdominal aortic aneurysmectomy. Am J Surg (1980) 1.00